Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in mitral and aortic regurgitation.

B A Carabello1

  • 1Department of Medicine, Baylor College of Medicine, and the Veterans Affairs Medical Center, Houston, TX 77030, USA.

Progress in Cardiovascular Diseases
|June 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of end-systolic pressure-volume analysis in clinical assessment of ventricular function.

Trends in cardiovascular medicine·2011
Same author

Indications for mitral valve surgery.

The Journal of cardiovascular surgery·2005
Same author

Normal myocardial function in severe right ventricular volume overload hypertrophy.

American journal of physiology. Heart and circulatory physiology·2000
Same author

The pathophysiology of mitral regurgitation.

The Journal of heart valve disease·2000
Same author

Microtubule depolymerization normalizes in vivo myocardial contractile function in dogs with pressure-overload left ventricular hypertrophy.

Circulation·2000
Same author

Left ventricular hypertrophy: pathogenesis, detection, and prognosis.

Circulation·2000

Therapy for valvular heart disease has evolved, with earlier surgical intervention for mitral and aortic regurgitation now recommended. Appropriate surgical timing improves longevity, even in asymptomatic patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardiovascular Medicine

Background:

  • Severe mitral and aortic regurgitation cause left ventricular damage and can be fatal.
  • Advancements in surgical techniques allow for earlier intervention in valvular heart disease.
  • Timely surgical correction can restore longevity comparable to the general population.

Purpose of the Study:

  • To discuss the evolving therapeutic landscape for valvular heart disease over the past 15 years.
  • To highlight the importance of appropriate surgical timing for mitral and aortic regurgitation.
  • To differentiate the pathophysiologies and surgical approaches for mitral versus aortic regurgitation.

Main Methods:

  • Review of current therapeutic strategies for valvular heart disease.

Related Experiment Videos

  • Analysis of the impact of surgical timing on patient outcomes.
  • Comparative discussion of mitral and aortic regurgitation characteristics.

    • Main Results:

    • Surgical intervention is increasingly indicated earlier, including for asymptomatic patients with severe regurgitation.
    • Mitral and aortic regurgitation present distinct pathophysiologies and require different surgical considerations.
    • Optimal surgical timing is crucial for mitigating left ventricular damage and improving survival.

    Conclusions:

    • Modern valvular heart disease therapy emphasizes early surgical intervention.
    • Understanding the differences between mitral and aortic regurgitation is key to successful surgical management.
    • Appropriate timing of surgery significantly impacts long-term patient outcomes and survival.